TrialsMajority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings, Study Finds

Published 9 June 2020

Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.